Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years

被引：0
|
作者：
Horinouchi, H. [1 ]
Ohe, Y. [1 ]
Yamanaka, Y. [2 ]
Kurata, T. [2 ]
Watanabe, K. [3 ]
Hosomi, Y. [3 ]
Nakahara, Y. [4 ]
Asao, T. [5 ]
Saeki, S. [6 ]
Tsubata, Y. [7 ]
Fujita, Y. [8 ]
Konishi, J. S. [9 ]
Mizugaki, H. [10 ]
Ohuchi, M. [11 ]
Yagishita, S. [11 ]
Hamada, A. [11 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Kansai Med Univ Hosp, Osaka, Japan
[3] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[4] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan
[5] Juntendo Univ Hosp, Tokyo, Japan
[6] Kumamoto Univ Hosp, Kumamoto, Japan
[7] Shimane Univ, Fac Med, Matsue, Shimane, Japan
[8] Jikei Univ, Sch Med, Tokyo, Japan
[9] Hokkaido Univ, Fac Med, Sapporo, Hokkaido, Japan
[10] JFCR, Canc Inst Hosp, Tokyo, Japan
[11] Natl Canc Ctr, Res Inst, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Pembrolizumab; pharmacokinetics; Elderly;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-08
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [21] Surgery of Stage I Non-Small Cell Lung Cancer in Patients Aged 70 Years or Older
    Kawamata, O.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1013 - S1013
  • [22] A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutations
    Hisashi Tanaka
    Kageaki Taima
    Yoshihito Tanaka
    Masamichi Itoga
    Yoshiko Ishioka
    Hideyuki Nakagawa
    Keisuke Baba
    Yukihiro Hasegawa
    Shingo Takanashi
    Sadatomo Tasaka
    Medical Oncology, 2018, 35
  • [23] A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutations
    Tanaka, Hisashi
    Taima, Kageaki
    Tanaka, Yoshihito
    Itoga, Masamichi
    Ishioka, Yoshiko
    Nakagawa, Hideyuki
    Baba, Keisuke
    Hasegawa, Yukihiro
    Takanashi, Shingo
    Tasaka, Sadatomo
    MEDICAL ONCOLOGY, 2018, 35 (03)
  • [24] Phase II Trial of Afatinib in Elderly Patients Aged Over 75 Years with EGFR Mutation Positive Non-Small Cell Lung Cancer
    Ko, R.
    Oizumi, S.
    Mizugaki, H.
    Fujita, Y.
    Harada, T.
    Takashina, T.
    Igawa, S.
    Watanabe, K.
    Hotta, T.
    Minemura, H.
    Saeki, S.
    Yagishita, S.
    Hamada, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S568 - S568
  • [25] Advanced non-small cell lung cancer - treatment with Pembrolizumab
    Silvinato, Antonio
    Floriano, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (03): : 256 - 256
  • [26] Pembrolizumab in non-small cell lung cancer: our experience
    Rizvi, S. A.
    Reza, S.
    Kabba, T.
    Ajzensztejn, D.
    Dwyer, M.
    Randhawa, R.
    Karina, M.
    LUNG CANCER, 2019, 127 : S83 - S83
  • [27] Advanced non-small cell lung cancer - Treatment with Pembrolizumab
    Silvinato, Antonio
    Floriono, Idevaldo
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (12): : 1423 - 1432
  • [28] Radiotherapy for non-small cell lung cancer in patients aged 75 and over: safety, effectiveness and possible impact on survival
    Lonardi, F
    Coeli, M
    Pavanato, G
    Adami, F
    Gioga, G
    Campostrini, F
    LUNG CANCER, 2000, 28 (01) : 43 - 50
  • [29] Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults
    Rawad Elias
    Joshua Morales
    Carolyn Presley
    Current Oncology Reports, 2017, 19
  • [30] Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer
    Tsukita, Yoko
    Tozuka, Takehiro
    Kushiro, Kohei
    Hosokawa, Shinobu
    Sumi, Toshiyuki
    Uematsu, Mao
    Honjo, Osamu
    Yamaguchi, Ou
    Asao, Tetsuhiko
    Sugisaka, Jun
    Saito, Go
    Shiihara, Jun
    Morita, Ryo
    Katakura, Seigo
    Yasuda, Takehiro
    Hisakane, Kakeru
    Miyauchi, Eisaku
    Morita, Satoshi
    Kobayashi, Kunihiko
    Asahina, Hajime
    JAMA ONCOLOGY, 2024, 10 (04) : 439 - 447
12345